Baxter International Inc (Baxter) is a provider of a range of healthcare products. Its product and service offerings include dialysis in acute and chronic conditions, sterile intravenous solutions, generic injectable pharmaceuticals, parenteral nutrition therapies, infusion systems and devices, inhaled anaesthetics and surgical hemostat and sealant products. The company’s products find application in hospitals, rehabilitation centres, kidney dialysis centres, nursing homes, and patients at home. Baxter distributes its products through direct sales force and a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Baxter International Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Baxter International Inc Company Overview
Baxter International Inc Company Snapshot
Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview
Baxter International Inc – Pipeline Analysis Overview
Business Description
Baxter International Inc - Key Facts
Baxter International Inc - Major Products and Services
Baxter International Inc Pipeline Products by Development Stage
Baxter International Inc Ongoing Clinical Trials by Trial Status
Baxter International Inc Pipeline Products Overview
Welch Allyn MacroView Plus Otoscope Product Overview
Welch Allyn PanOptic Plus Ophthalmoscope
Welch Allyn PanOptic Plus Ophthalmoscope Product Overview
Baxter International Inc - Key Competitors
Baxter International Inc - Key Employees
Baxter International Inc - Key Employee Biographies
Baxter International Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Baxter International Inc, Recent Developments
Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format
Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results
Sep 07, 2022: Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors
Aug 31, 2022: Baxter announces U.S. FDA clearance of Novum IQ Syringe Infusion Pump with Dose IQ Safety Software
Aug 11, 2022: Baxter issues urgent medical device recall of Clearlink Solution Set 2R8403 due to potential risk of leaking complications
Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
Jun 01, 2022: Baxter Issues Urgent Medical Device Correction to Reinforce Important Safety Information Regarding Possible Risk of Oxygen Desaturation While Using Volara Device in Line With Ventilator in a Home Care Environment
May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
May 10, 2022: Baxter to Host 2022 Investor Conference
Apr 19, 2022: Baxter highlights new data at SCCM critical care congress showing hemodynamic monitoring may help predict patient outcomes
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview
Baxter International Inc Pipeline Products by Equipment Type
Baxter International Inc Pipeline Products by Indication
Baxter International Inc Ongoing Clinical Trials by Trial Status
Baxter International Inc, Key Facts
Baxter International Inc, Major Products and Services
Baxter International Inc Number of Pipeline Products by Development Stage
Baxter International Inc Pipeline Products Summary by Development Stage
Baxter International Inc Ongoing Clinical Trials by Trial Status
Baxter International Inc Ongoing Clinical Trials Summary
ACCUREACH - Product Status
ACCUREACH - Product Description
Ambulatory Pump - Product Status
Ambulatory Pump - Product Description
Arterial Everter - Product Status
Arterial Everter - Product Description
Artis Dialysis System - Product Status
Artis Dialysis System - Product Description
Automated AF Detector - Product Status
Automated AF Detector - Product Description
CWP 800 Mini - Product Status
CWP 800 Mini - Product Description
DurADAPT Bioimplant - Product Status
DurADAPT Bioimplant - Product Description
Ecocapture - Product Status
Ecocapture - Product Description
ENFit Enteral Syringe - Product Status
ENFit Enteral Syringe - Product Description
Floseal + Recothrom 10mL - Product Status
Floseal + Recothrom 10mL - Product Description
Gem zipclip - Product Status
Gem zipclip - Product Description
Infusion Pump - Product Status
Infusion Pump - Product Description
LINQ Mobile App - Product Status
LINQ Mobile App - Product Description
Next-Gen Allen Advance Table - Product Status
Next-Gen Allen Advance Table - Product Description
Next-Gen Respiratory Therapy Device - Product Status
OCT Imaging Device - Eardrum - Product Description
Ovart 3D Biodegradable Matrix - Product Status
Ovart 3D Biodegradable Matrix - Product Description
oXiris - Product Status
oXiris - Product Description
oXiris - A Pilot Multicentre Open-Label Randomized Controlled Trial During Treatment for Acute Kidney Injury in Critically Ill Patients with Septic Shock Comparing Two Haemofilter Membrane Devices, The An69st and the Newly Available Oxiris Haemofiltration Membrane for Early Resolution of Shock As Well As Other Clinical and Technical Performance Outcomes
oXiris - A Randomized, Controlled Trial to Evaluate Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) in Comparison with a Semi Selective Semipermeable Membrane (Standard AN-69) in COVID-19 Associated Acute Kidney Injury: oXAKI-COV Study
oXiris - Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy with a High Adsorption Membrane (oXiris)
oXiris - Clinical Study of Microcirculatory Parameters in Septic/Septic Shock Patients Treated with Oxiris Filter
oXiris - Effect of Oxiris Membrane on Microcirculation Following Cardiac Surgery Under Cardiopulmonary Bypass: A Pilot Prospective Monocentric Study (Oxicard Study)
oXiris - Effects of Removal of Endotoxin, Cytokines, and Uremic Toxins Using Blood Purification on Patients with Severe Septic Shock
oXiris - Endotoxins and Cytokines Removal During Continuous Hemofiltration with oXiris
oXiris - Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated with Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIX
oXiris - Real-time Monitoring of Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy: Propensity Score-matched Comparison Between oXiris and Polysulfone Membranes
oXiris - Renal Replacement Therapy with a Cytokine Absorption Filter (oXiris) in Patients with Septic Shock: a Case-control Study Nested in a Cohort
oXiris - The Effect of a Hemoperfusion with Polyethyleneimine-coated Membrane Filter (Oxiris) in Patients with Septic Shock: A Multicenter Randomized Controlled Trial
oXiris - The Effects of Extracorporeal Blood Purification (oXiris) in Patients with Cardiogenic Shock Requiring VA-ECMO: A Prospective, Open-label, Randomized Controlled Pilot Study
oXiris - The Effects of oXiris on Systemic Inflammation, Endothelial Dysfunction and Volume Control in Cardiac Surgery Patients Undergoing Cardiopulmonary Bypass
oXiris - The Efficacy of Different Mode of Blood Purification in Septic Children
Peritoneal Dialysis Solution Generation System - Product Status
Peritoneal Dialysis Solution Generation System - Product Description
Peritoneal Dialysis Solution Generation System - Improvement of Home Dialysis and to Simplify therapy Management Using On-demand Peritoneal Dialysis Solution System: US Clinical Study
PIVA Hemodynamic Monitoring System - Product Status
PIVA Hemodynamic Monitoring System - Product Description
Point of Care Generation 1 System - Product Status
Point of Care Generation 1 System - Product Description
Point of Care Generation 2 System - Product Status
Point of Care Generation 2 System - Product Description
PrismaLung+ - Product Status
PrismaLung+ - Product Description
PrismaLung+ - A Novel ECCO2R Device as a Lung Protective Measure in Hypercapnic Respiratory Failure: A Prospective Multicenter Trial
PrismaLung+ - A Post-market Study of Performance and Safety of Low-flow Extracorporeal Carbon Dioxide Removal Using PrismaLung+ in Patients with Mild to Moderate Acute Respiratory Distress Syndrome